Terramera announced today it has raised US$45 million in equity funding to advance its Actigate™ Targeted Performance technology.

Terramera is a cleantech leader focused on fusing AI, science and nature to create revolutionary technologies that transform how we grow food and solve other world-scale challenges.

The Series B round was led by new investor Ospraie Ag Science and previous investor Seed2Growth Ventures (S2G). The funds raised will enable Terramera to scale its technology and transform agriculture while positively impacting the environment and the well-being of people worldwide.

The company also announced the appointment of BuildDirect Founder Jeff Booth as Board Chair and Ospraie Ag Science lead investor and Ag industry veteran Carl Casale to its Board of Directors.

“We are on the path to reduce global synthetic chemical loads in agriculture by 80% by 2030 with Actigate,” said Karn Manhas, Terramera Founder and CEO. “We are grateful for the support of Ospraie Ag Science and S2G Ventures, as they will be instrumental to fulfilling our mission of using technology to unlock the intelligence in nature, ensuring an earth that thrives and provides for everyone.”

Terramera’s Actigate technology significantly improves the performance of active ingredients used in crop protection products, dramatically reducing the amount required. Actigate improves performance of both natural and conventional active ingredients. The result is higher-performing organic biopesticides and less synthetic chemicals in farming. This lowers costs across the system, improves farm productivity and profitability, reduces waste and minimizes environmental impact.

“Terramera’s technology fuses AI, science and nature to create game-changing solutions for agriculture and pest control that will better our lives and ensure the sustainable future of our planet,” added Manhas. “We can’t do it alone. We want to work with others who share our vision to accomplish our 2030 goals and accelerate the impact we can have on our earth.”